DALLAS, Aug. 1, 2018 /PRNewswire/ -- Wellbridge Healthcare today announced that Gregory D. Drummondhas been appointed Chief Executive Officer of the WellBridge Hospital in San Marcos. Mr. Drummond is a seasoned behavioral health executive with strong roots in the San Marcos area.
Drummond played football
"We are very fortunate to have someone of Greg's caliber and experience to lead our hospital in San Marcos," said Scott Wilson, Chairman. "Greg brings proven leadership and regional expertise to expand our successful inpatient and outpatient programs. He embodies the passion behind our mission to be the best mental health provider in every community that we serve."
"I am honored and excited to lead WellBridge San Marcos. I look forward to building on our success and expanding services to meet the broader needs of our community. Mental health and wellbeing has been my passion since I graduated from Texas State, and I am thrilled to be back in this area," Drummond said.
WellBridge San Marcos is a behavioral health hospital offering a continuum of behavioral healthcare services, from inpatient beds to outpatient therapy for adults and seniors throughout the Central Texas region.
ABOUT WELLBRIDGE HEALTHCARE
WellBridge Healthcare is a regional leader in behavioral health operating multiple inpatient and outpatient behavioral healthcare locations in Texas. Founded in 2014, WellBridge Healthcare provides innovative behavioral health services to senior and adult patients with a focus on treating cognitive and progressive mental health symptoms. For further information, visit www.wellbridgehealthcare.com
View original content:http://www.prnewswire.com/news-releases/respected-behavioral-health-leader-gregory-d-drummond-joins-wellbridge-hospital-san-marcos-as-chief-executive-officer-300690579.html
SOURCE Wellbridge Healthcare
Subscribe to our Free Newsletters!
Collagen plays a crucial role in glowing skin, strong nails and shiny hair. You can boost collagen ...
CRISPR technology is a simple but potent tool for editing any part of the genome (complete set of ...
FDA recently approved Mogamulizumab-kpkc, a human monoclonal antibody prescribed for adult ...View All